- Home
- XIFR vs AVDL Comparison
XIFR vs AVDL Comparison
Compare XIFR & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XIFR
- AVDL
- Stock Information
- Founded
- XIFR 2014
- AVDL 2015
- Country
- XIFR United States
- AVDL Ireland
- Employees
- XIFR N/A
- AVDL N/A
- Industry
- XIFR
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- XIFR
- AVDL Health Care
- Exchange
- XIFR NYSE
- AVDL Nasdaq
- Market Cap
- XIFR 847.9M
- AVDL 861.4M
- IPO Year
- XIFR N/A
- AVDL 1996
- Fundamental
- Price
- XIFR $9.23
- AVDL $11.08
- Analyst Decision
- XIFR Hold
- AVDL Strong Buy
- Analyst Count
- XIFR 4
- AVDL 7
- Target Price
- XIFR $10.75
- AVDL $18.71
- AVG Volume (30 Days)
- XIFR 1.0M
- AVDL 1.0M
- Earning Date
- XIFR 08-07-2025
- AVDL 08-07-2025
- Dividend Yield
- XIFR 19.75%
- AVDL N/A
- EPS Growth
- XIFR N/A
- AVDL N/A
- EPS
- XIFR N/A
- AVDL N/A
- Revenue
- XIFR $1,255,000,000.00
- AVDL $194,450,000.00
- Revenue This Year
- XIFR $9.02
- AVDL $56.78
- Revenue Next Year
- XIFR $1.94
- AVDL $30.46
- P/E Ratio
- XIFR N/A
- AVDL N/A
- Revenue Growth
- XIFR 15.14
- AVDL 252.64
- 52 Week Low
- XIFR $7.53
- AVDL $6.38
- 52 Week High
- XIFR $28.25
- AVDL $17.30
- Technical
- Relative Strength Index (RSI)
- XIFR N/A
- AVDL 63.51
- Support Level
- XIFR N/A
- AVDL $10.53
- Resistance Level
- XIFR N/A
- AVDL $11.03
- Average True Range (ATR)
- XIFR 0.00
- AVDL 0.45
- MACD
- XIFR 0.00
- AVDL -0.02
- Stochastic Oscillator
- XIFR 0.00
- AVDL 73.33
About XIFR XPLR INFRASTRUCTURE LP
XPLR Infrastructure LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.